Incidence, Characteristics, and Outcomes of Clinically Undetected Bacteremia in Children Discharged Home From the Emergency Department

Background: Despite a recent decline in the rates of invasive infections, bacteremia in young children remains a significant challenge. We aimed to describe patient characteristics, microbial etiology, and outcomes of bacteremic, well-appearing children 3–36 months of age who were discharged home from the pediatric emergency department (PED) on their index visit. Methods: A retrospective cohort study in the PED of a tertiary children’s hospital from 1 June 2015 until 30 June 2021. We included all well appearing, immunocompetent infants 3–36 months old evaluated for fever and discharged home from the PED after a blood culture was drawn. We extracted demographic, clinical and laboratory data from the patient’s electronic medical records for the index visit and subsequent encounters. Results: During the study period, 17,114 children evaluated for fever met the inclusion criteria. Seventy-two patients (0.42%) had positive cultures for known pathogens. Thirty-six (50%) were male and 36 (50%) younger than 1 year. The most common isolates were S. pneumonia 26%. (n = 19), K. Kingae 25%. (n = 18) and Salmonella spp. 13.9% (n = 10). Sixty patients (85.7%) were recalled to the ED or had a scheduled appointment, 10 (14.3%) returned spontaneously and two were followed up by phone. The median time between visits was 28.7 hours (IQR 19.1–41.1). One patient was admitted to intensive care during the course of hospitalization. There were no deaths. Conclusion: The rate of undetected true bacteremia in our study was low and our data suggest that significant clinical deterioration during the first 24 hours is rare.

[1]  N. Kuppermann,et al.  Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old , 2021, Pediatrics.

[2]  E. Segal,et al.  Prediction of gestational diabetes based on nationwide electronic health records , 2020, Nature Medicine.

[3]  N. Team.  Fever in under 5s: assessment and initial management , 2019 .

[4]  R. Dagan,et al.  Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction , 2018, The Pediatric infectious disease journal.

[5]  Stanley Lemeshow,et al.  Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric Sepsis , 2018, JAMA.

[6]  J. García-García,et al.  Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  B. Krauss,et al.  Fever in Children: Pearls and Pitfalls , 2017, Children.

[8]  L. First.  The State of Our Bacteremia Nation Post the Arrival of Conjugated Pneumococcal Vaccines in Children 3 to 36 Months Old , 2017 .

[9]  A. Herz,et al.  Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines , 2017, Pediatrics.

[10]  D. Greenberg,et al.  Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012). , 2016, Pediatrics and neonatology.

[11]  P. Diggle,et al.  Etiology of Childhood Bacteremia and Timely Antibiotics Administration in the Emergency Department , 2015, Pediatrics.

[12]  J. García-García,et al.  Bacteremia in previously healthy children in Emergency Departments: clinical and microbiological characteristics and outcome , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  D. Schriger,et al.  Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. , 2014, Annals of emergency medicine.

[14]  E. Alpern,et al.  Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination. , 2013, The Journal of emergency medicine.

[15]  M. S. Murphy,et al.  Assessment and initial management of feverish illness in children younger than 5 years: summary of updated NICE guidance , 2013, BMJ.

[16]  J. Hamilton,et al.  Evaluation of fever in infants and young children. , 2013, American family physician.

[17]  Alan E. Simon,et al.  Emergency Department Laboratory Evaluations of Fever Without Source in Children Aged 3 to 36 Months , 2011, Pediatrics.

[18]  J. S. St. Geme,et al.  Kingella kingae: An Emerging Pathogen in Young Children , 2011, Pediatrics.

[19]  M. Gausche-Hill,et al.  The Pediatric Assessment Triangle: A Novel Approach for the Rapid Evaluation of Children , 2010, Pediatric emergency care.

[20]  M. Wilkinson,et al.  Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[21]  R. Riffenburgh,et al.  Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. , 2007, Annals of emergency medicine.

[22]  S. Black,et al.  Changing Epidemiology of Outpatient Bacteremia in 3- to 36-Month-Old Children After the Introduction of the Heptavalent-Conjugated Pneumococcal Vaccine , 2006, The Pediatric infectious disease journal.

[23]  M. Harper,et al.  Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. , 2001, Pediatrics.

[24]  L. Baraff.  Management of fever without source in infants and children. , 2000, Annals of emergency medicine.

[25]  K. Krisher,et al.  Comparison of the BacT/Alert pediatric blood culture system, Pedi-BacT, with conventional culture using the 20-milliliter Becton-Dickinson supplemented peptone broth tube , 1993, Journal of clinical microbiology.